AstraZeneca's (AZN) Fasenra sBLA for Nasal Polyps Gets CRL
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN announced that the FDA has issued a complete response letter to its supplemental...
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
Benzinga via Yahoo Finance· 7 months agoAstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra...
Pennsylvania woman stunned to be charged $50K for asthma medication. No one can explain it
USA TODAY via Yahoo News· 8 months agoYORK, Pa. — Jessica Eckard has always had asthma problems. Her father died of tuberculosis when she...
FDA Declines To Approve AstraZeneca's Asthma Treatment For Chronic Nasal Condition
Benzinga via Yahoo Finance· 1 year agoThe FDA has declined to approve AstraZeneca Plc's (NASDAQ: AZN) asthma medicine, Fasenra...
AstraZeneca drug fails one main goal in study of chronic immune disease
Reuters via Yahoo News· 7 months agoThe condition, eosinophilic esophagitis, is characterised by inflammation and damage to the...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 7 months agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 4 months agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 month agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
Zacks via Yahoo Finance· 3 months agoAstraZeneca’s AZN stock has risen 5.1% in the past year compared with an increase of 2% for the...
Glaxo's (GSK) Nucala Gets CHMP Nod for 3 Diseases in Europe
Zacks via Yahoo Finance· 2 years agoGlaxo (GSK) is seeking approval of Nucala for hypereosinophilic syndrome, eosinophilic...